More than 200 people celebrated the 2022 Facility of the Year Award Winners at a reception and banquet Sunday night at the 2022 ISPE Annual Meeting & Expo at the Gaylord Palms in Orlando, Florida.
More than 200 people celebrated the 2022 Facility of the Year Award Winners at a reception and banquet Sunday night at the 2022 ISPE Annual Meeting & Expo at the Gaylord Palms in Orlando, Florida.
At the ISPE Singapore Conference on 17 August 2022 during an online panel discussion, four international regulators discussed how the Covid-19 pandemic had taught regulators to look for alternative ways of conducting GMP inspections and also to rely more on each other to make determinations on the GMP status of manufacturers of medicines.
We are The Culture Club, a self-formed cross-CoP group of individuals who came together to discuss the quality/validation challenges encountered as we transition into the digital world and identify ways to influence cultural changes needed within our industry to better enable innovation. This blog is the first in a 4 part series intended to explore how we can rethink the way we support and...
It is a great honour and pleasure for me as the 2022-2023 ISPE Board Past Chair and Chair of the 2023 ISPE Aseptic Conference Program Committee to give you a first glimpse at the program and of the information and...
ISPE’s Transportable/Point of Care (PoC) Manufacturing Technology team, a working group under the Product Quality Lifecycle Implementation (PQLI)® committee, is presenting a session entitled Transportable, Small Footprint Biopharmaceutical Manufacturing Facilities: A Regulatory Perspective at the 2022 ISPE Annual Meeting & Expo on Monday, 31 October at 1100–1230 as part of the...
Helping people, projects and companies succeed are the aspects Dharti Pancholi has enjoyed most about her career in the pharmaceutical industry. “I really like empowering people whether it is my team or my clients. It is great to bring together people who have a diverse set of experiences, skills, or perspectives, who might not normally work together, and collectively develop something, grow a...
Global demand for plasma-derived therapies (PDTs) continues to swell—the compacting result of an aging population, clinical successes, and recent applications for both widespread diseases and multiple rare conditions. Serving these needs has been a significant challenge over the last two and a half years, with a decline in plasma donations due to the COVID-19 pandemic. The donation shortage...